Why Bristol Myers Squibb Stock Is Sinking Today
Published
Investors didn't like the biopharmaceutical company's updated guidance.
Full ArticlePublished
Investors didn't like the biopharmaceutical company's updated guidance.
Full ArticleBristol Myers Squibb faces some challenges, but there could be light at the end of the tunnel for long-term investors.
Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500..